Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on July 29, 2021, to report its financial results for the second quarter of 2021. The key takeaway from this filing is the issuance of a press release containing the company's performance metrics for the period ending June 30, 2021. While the 8-K itself is a brief document primarily referencing the press release, investors should refer to the furnished Exhibit 99.1 for the detailed financial and operational data.
Key Highlights
- 1Edwards Lifesciences released its Q2 2021 financial results via an 8-K filing on July 29, 2021.
- 2The filing serves to formally incorporate the company's Q2 2021 earnings press release as an exhibit.
- 3Investors are directed to the press release (Exhibit 99.1) for specific financial performance details of the second quarter.
- 4The 8-K does not contain the detailed financial results itself but references the accompanying press release.
- 5The event date for reporting these results was July 28, 2021, with the filing occurring on July 29, 2021.